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1. INTRODUCTION 
Most lectins described to this date have been 
isolated from the seeds of leguminous plants. One 
such lectin is the glycoprotein isolated from the 
seeds of the Dolichos biflorus plant expressing an 
activity for terminal non-reducing a-linked N- 
acetyl-D-galactosamine r sidues [11. In addition to 
this seed lectin the stems and leaves of the Dolichos 
bijlorus plant contain another glycoprotein that 
crossreacts with antibodies against the lectin from 
the seeds of this plant. This cross-reactive material 
(CRM) was isolated and characterized 121 and was 
shown to have an amino acid and carbohydrate 
composition very similar to that of the seed lectin 
12~31. 
CRM and the seed lectin both contain appar- 
ently equal amounts of two types of subunits; one 
CRM subunit is identical in electrophoretic mobil- 
ity to subunit I of the seed lectin [2]. Both CRM 
subunits have. a NHz-terminal amino acid se- 
quence identical to the sequence of the seed lectin 
subunits with the exception of an aspartate in 
place of an asparagine at the second residue [2,4]. 
It has also recently been shown that CRM, at low 
ionic strength, has carbohydrate binding activity 
[S] although its specificity is somewhat broader 
that that of the seed lectin. 
Despite this close structural resemblance be- 
tween these two carbohydrate binding proteins 
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from the Dolichos biyorus plant we now report a 
distinct in vitro difference in mitogenic activity. 
2. MATERIALS AND METHODS 
2.1. Materials and methods 
Dolichos biflorus seeds were obtained from F.W. 
Schumacher Co., Sandwich, MA. Blood group 
A+ H substance (BGS) was isolated by ethanol 
precipitation [6] from hog gastric mucin (Wilson 
laboratories, Chicago, IL). 
2.2. Purification of seed lectin and CRM 
The Dolichos bi’orus seed lectin was isolated 
from seed extract as previously described [3] by ad- 
sorption of the lectin onto insoluble polyleucyl hog 
blood group A + H substance and specific elution 
with 0.01 M N-acetyl-D-galactosamine. After re- 
moval of the hapten by chromatography on Bio- 
Gel P-10, the lectin was concentrated by ultra- 
filtration in a Diaflow ultrafiltration device using a 
PM-10 filter. CRM was also isolated by affinity 
chromatography using BGS-Sepharose as pre- 
viously described [S] and eluted by raising the 
ionic strength. 
2.3. Neuraminidase treatment qf isolated lympho- 
cytes 
Venous blood obtained from a healthy human 
donor was heparin treated and the lymphocytes 
were prepared by Ficoll-Isopaque (Pharmacia 
Fine Chemicals, Uppsala, Sweden) centrifugation. 
20 X 106, cells were incubated at 37°C for 45 min 
with 60 pg neuraminidase (Clostridium perfringens, 
type VI 5 U/mg protein NAN-lactose substrate. 
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Sigma St. Louis, MO) in 1.5 ml Tris-buffered 
Hanks solution (pH 7.4) [7,].# 
2.4. Mitogenic assay 
Activation of the neuraminidase-treated human 
peripheral ymphocytes was measured as the incor- 
poration of [meth_@H]thymidine (2.0 Ci/mmol) 
(New England Nuclear) into the cells. One ml lym- 
phocytes (0.5 x 106 cell/ml) in RPM1 1640 (Gibco 
Biocult Ltd.) supplemented with 10% fetal calf- 
serum, 5 mM L-glutamine, streptomycin (50 r_lg/ 
ml) and penicillin (50 W/ml), and 1% 100x non- 
essential amino acids (Flow Laboratories, Inc.) 
were incubated for 96 h in 15 mm Linbro wells in 
the presence of CRM (2.5-200 yg/ml) or seed lec- 
tin (3-300 pg/ml). After 72 h at 37°C the cells 
were pulsed for 24 h with 2 PCi [methyl3H]thy- 
midine/well. The cells were then transferred to 
0.45 pm Millipore filters and washed twice with 
2 ml cold 0.01 M phosphate-buffered saline 
(pH 7.2) and twice with 5 ml 10% trichloroacetic 
acid. After a final wash with 3 x 2 ml 95% ethanol 
the filters were dried and the radioactivity of the 
insoluble material was determined by liquid scin- 
tillation counting in a toluene based scintillation 
cocktail. 
3. RESULTS AND DISCUSSION 
The two carbohydrate binding proteins from the 
Dolichos bzjlorus plant were tested in their ability 
to stimulate human peripheral lymphocytes to in- 
corporate radiolabelled thymidine. Despite the 
structural resemblance between these two proteins 
a distinct difference appeared in their induction of 
in vitro mitogenic activity. The two carbohydrate- 
binding proteins were initially tested using human 
peripheral lymphocytes isolated by density cen- 
trifugation. Under these circumstances neither of 
the two lectins was able to induce cell proliferation 
which in the case of the Dolichos bzporus seed lec- 
tin is in agreement with other reports concerning 
mitogenic activity [7]. However, when terminal 
sialic acid residues were removed from glycocon- 
jugates on the surface of the isolated lymphocytes 
using neuraminidase a significant difference in the 
biological activity of the two lectins was found. 
CRM was able to induce proliferation of the neur- 
aminidase-treated peripheral ymphocytes whereas 
the seed lectin did not show any mitogenic activity. 
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Fig.]. Stimulation of neuraminidase-treated human pe- 
ripheral lymphocytes by CRM (O-O) and the seed lec- 
tin (e-e). % Stimulation = ((cpm in presence of lec- 
tin/cpm in absence of lectin) - 1)~ 100. All samples 
were run in duplicates. 
As can be seen from fig. 1 the Dolichos biJorus seed 
lectin did not activate the cells when tested in the 
range of 3-300 pg lectin/mg whereas CRM stimu- 
lated the growth of the lymphocytes with a dose re- 
sponse maximum at 70 pg CRM/ml when tested in 
the range of 2.5-200 PLg CRM/ml. 
The dose-response maximum of different 
mitogenic lectins varies over a wide range; a max- 
imum of 5 pg/ml has been reported for phy- 
tohemagglutinin (PHA), the seed lectin from Pha- 
seolus vulgaris whereas over 100 pg/ml of soy bean 
agglutinin (SBA) is required for maximum stim- 
ulation 181. This difference seems partly due to pa- 
rameters uch as binding affinity, valence and car- 
bohydrate binding specificity of the lectins. The 
state of aggregation and consequently the valence 
of lectins have been shown to be closely related to 
their mitogenic activity [8,9]. The somewhat ele- 
vated dose response maximum of CRM might be 
explained by the fact that this stem and leaf lectin 
is a dimeric protein consisting of two different 
types of subunits most probably giving it a low val- 
ence. The binding affinity of CRM to carbohy- 
drate containing cell-surface structures, its content 
of tightly bound divalent cations [lo] and the 
somewhat different carbohydrate binding specif- 
icity [S] compared to the Dolichos bzji’orus seed lec- 
tin might also contribute to the above difference in 
mitogenic activity. 
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